Rockland Immunochemicals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Rockland Immunochemicals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7549
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rockland Immunochemicals Inc (Rockland) is a biotechnology company that manufactures research tools for basic, applied and clinical research in functional genomics, drug discovery, gene therapy markets. The company’s products include collagen products, primary and secondary antibodies, Epi-Plus, blood products, GFP Antibodies, blocking buffers, proteins and peptides, fluorescent TrueBlot, phospho-specific, and melanoma cell lines, among others. It offers services such as custom peptide services, antibody purification, custom antibody production, cell culture services, custom assay development, antibody fragmentation and generation, custom conjugations, IHC studies and IVD service solutions. Rockland produces antibodies and antibody-based tools used to help mechanisms underlying cell function and disease. The company markets its products through distributors in the US, Austria, Belgium, Australia, Brazil, Canada, Chile and Denmark among others. Rockland is headquartered in Limerick, Pennsylvania, the US.

Rockland Immunochemicals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rockland Immunochemicals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Rockland Immunochemicals Acquires Epi-Plus Product Line From Twentyfirst Century Biochemicals 11
Partnerships 12
Formula Pharma Enters into Co-Development Agreement with Rockland Immunochemicals 12
Rockland Immunochemicals Enters Into Co-Development Agreement With National Cancer Institute 13
Licensing Agreements 14
Rockland Immunochemicals Expands Licensing Agreement With LIMR Development 14
Rockland Immunochemicals Enters Into Licensing Agreement With LIMR Development 15
Rockland Immunochemicals Inc – Key Competitors 16
Rockland Immunochemicals Inc – Key Employees 17
Rockland Immunochemicals Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rockland Immunochemicals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Rockland Immunochemicals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rockland Immunochemicals Acquires Epi-Plus Product Line From Twentyfirst Century Biochemicals 11
Formula Pharma Enters into Co-Development Agreement with Rockland Immunochemicals 12
Rockland Immunochemicals Enters Into Co-Development Agreement With National Cancer Institute 13
Rockland Immunochemicals Expands Licensing Agreement With LIMR Development 14
Rockland Immunochemicals Enters Into Licensing Agreement With LIMR Development 15
Rockland Immunochemicals Inc, Key Competitors 16
Rockland Immunochemicals Inc, Key Employees 17

List of Figures
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rockland Immunochemicals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rockland Immunochemicals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Rockland Immunochemicals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fugro GeoServices Ltd:企業の戦略的SWOT分析
    Fugro GeoServices Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • KeyCorp (KEY):電力:M&Aディール及び事業提携情報
    Summary KeyCorp (KeyCorp) is a bank holding company that offers a range of retail and commercial banking, consumer finance, commercial mortgage and special servicing, commercial leasing, investment management, and investment banking products and services through its principle subsidiary, KeyBank Nat …
  • Nabriva Therapeutics plc (NBRV):企業の財務・戦略的SWOT分析
    Summary Nabriva Therapeutics Plc (Nabriva) is a biopharmaceutical company that researches and develops antibiotics for the treatment of infections. The company offers product candidate such as Xenleta (lefamulin), CONTEPO (fosfomycin), being developed in both intravenous and oral formulations for th …
  • Redcape Hotel Group:企業の戦略・SWOT・財務情報
    Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report Summary Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Health Dialog Services Corp:企業の戦略的SWOT分析
    Health Dialog Services Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • The Saudi British Bank (1060):企業の財務・戦略的SWOT分析
    The Saudi British Bank (1060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Hanwha Q CELLS Co Ltd (HQCL):電力:M&Aディール及び事業提携情報
    Summary Hanwha Q CELLS Co Ltd (Q CELLS) is a vertically integrated solar solution provider. It develops, manufactures and sells solar cells and modules. The company produces a wide range of PV cells and modules, and silicon ingots; and provides EPC services for the development and installation of gr …
  • Ardian Holding SAS:企業の戦略的SWOT分析
    Ardian Holding SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Brainsway Ltd (BRIN):企業の財務・戦略的SWOT分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Vectura Group Plc (VEC):医療機器:M&Aディール及び事業提携情報
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • Randgold Resources Limited:企業の戦略・SWOT・財務情報
    Randgold Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Randgold Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Helios and Matheson Analytics Inc (HMNY):企業の財務・戦略的SWOT分析
    Summary Helios and Matheson Analytics Inc (Helios and Matheson) is a big data company. It offers IT infrastructure, social data aggregation, cognitive computing, map-tech innovation, application development, pattern discovery solutions. The company's analytic solutions find application across a broa …
  • Redington (India) Limited (REDINGTON):企業の財務・戦略的SWOT分析
    Redington (India) Limited (REDINGTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • The AES Corporation:企業の戦略・SWOT・財務分析
    The AES Corporation - Strategy, SWOT and Corporate Finance Report Summary The AES Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • UAC of Nigeria PLC:企業の戦略・SWOT・財務情報
    UAC of Nigeria PLC - Strategy, SWOT and Corporate Finance Report Summary UAC of Nigeria PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hallador Energy Co (HNRG):企業の財務・戦略的SWOT分析
    Hallador Energy Co (HNRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Companhia Riograndense de Mineracao:企業の戦略・SWOT・財務情報
    Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report Summary Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Acceleron Pharma Inc (XLRN):製薬・医療:M&Aディール及び事業提携情報
    Summary Acceleron Pharma Inc (Acceleron Pharma) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutics to treat serious and rare diseases. The company’s lead therapeutic candidate, luspatercept, is in phase 3 studyused for the treatment of the myelodys …
  • Fagron NV (FAGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Fagron NV (Fagron), formerly Arseus NV is a pharmaceutical compounding solution provider. The company offers products such as raw materials, extracts and tinctures, flammable products, anesthesia, ointment bases, syrups, suspension media, triturations, phyto pharmaflore, medispend, capsicard …
  • Nerviano Medical Sciences Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Nerviano Medical Sciences Srl (NMS) is a drug development company that discovers and develops novel anticancer drugs. The company's pipeline products include anticancer compounds such as Danusertib, Encorafenib, Entrectinib, ADC Payload programs, PARP1 program, NMS-088, Brostallicin, Milcicl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆